4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-228339
Chief Medical Officer sold 12,039 shares at $14.58 ($175,518)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bedrosian Camille L Chief Medical Officer | 2025-09-30 | Sale | −12,039 | $14.58 | $175,518 | 182,336 | D: show line 1 in the form |
| Open-market sales · 12,039 sh · avg $14.58 · $175,518 | |||||||
Loading xslF345X05/ownership.xml…